Suzan M. Hammond

2.2k citations

32 papers · 1.4k indexed · h-index 17

Co-authors: Matthew J. A. Wood Michael J. Gait Corinne Betts Andrey Arzumanov Amer F. Saleh Caroline Godfrey Thibault Coursindel Graham McClorey
Topics: Neurogenetic and Muscular Disorders Research (14 papers)Muscle Physiology and Disorders (12 papers)RNA Interference and Gene Delivery (12 papers)
Cited by: Genetics Molecular Biology
Journals: Proceedings of the National Academy of Sciences Nucleic Acids Research Blood
Partner nations: United Kingdom United States Sweden

In The Last Decade

Suzan M. Hammond

32 papers receiving 1.4k citations

Peers

Countries citing papers authored by Suzan M. Hammond

Since Specialization

Citations

This map shows the geographic impact of Suzan M. Hammond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzan M. Hammond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzan M. Hammond more than expected).

Fields of papers citing papers by Suzan M. Hammond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzan M. Hammond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzan M. Hammond. The network helps show where Suzan M. Hammond may publish in the future.

Co-authorship network of co-authors of Suzan M. Hammond

This figure shows the co-authorship network connecting the top 25 collaborators of Suzan M. Hammond. A scholar is included among the top collaborators of Suzan M. Hammond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzan M. Hammond. Suzan M. Hammond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibody-oligonucleotide conjugate achieves CNS delivery in animal models for spinal muscular atrophy 2022 ·JCI Insight ·Suzan M. Hammond,Frank Abendroth,(unknown),(unknown),Matthew Burrell,George Thom,Ian Gurrell,Nina Ahlskog,Michael J. Gait,Matthew J. A. Wood,Carl I. Webster	34
2	Evaluating Efficacy of Peptide-Delivered Oligonucleotides Using the Severe Taiwanese SMA Mouse Model 2021 ·Methods in molecular biology ·(unknown),(unknown),Suzan M. Hammond,(unknown)	1
3	Mesyl Phosphoramidate Oligonucleotides as Potential Splice-Switching Agents: Impact of Backbone Structure on Activity and Intracellular Localization 2021 ·Nucleic Acid Therapeutics ·Suzan M. Hammond,Olga V. Sergeeva,Pavel Melnikov,(unknown),(unknown),Timofei S. Zatsepin,Dmitry A. Stetsenko,Matthew J. A. Wood	16
4	Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophy 2021 ·JCI Insight ·Katharina E. Meijboom,Viola Volpato,Jimena Monzón‐Sandoval,(unknown),Suzan M. Hammond,Frank Abendroth,Olivier G. de Jong,(unknown),Nina Ahlskog,Matthew J. A. Wood,Caleb Webber,Mélissa Bowerman	13
5	Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy 2021 ·Molecular Therapy — Nucleic Acids ·(unknown),Christopher Grunseich,George G. Harmison,(unknown),Carlo Rinaldi,Suzan M. Hammond,Kory Johnson,Mélissa Bowerman,(unknown),Kevin Talbot,Matthew J. A. Wood,Kenneth H. Fischbeck	14
6	Muscle overexpression of Klf15 via an AAV8-Spc5-12 construct does not provide benefits in spinal muscular atrophy mice 2020 ·Gene Therapy ·Nina Ahlskog,Daniel Hayler,A. P. Krueger,(unknown),Peter Claus,Suzan M. Hammond,Matthew J. A. Wood,Rafael J. Yáñez‐Muñoz,Mélissa Bowerman	6
7	Cell-Penetrating Peptide Conjugates of Steric Blocking Oligonucleotides as Therapeutics for Neuromuscular Diseases from a Historical Perspective to Current Prospects of Treatment 2018 ·Nucleic Acid Therapeutics ·Michael J. Gait,Andrey Arzumanov,Graham McClorey,Caroline Godfrey,Corinne Betts,Suzan M. Hammond,Matthew J. A. Wood	65
8	Implications for Cardiac Function Following Rescue of the Dystrophic Diaphragm in a Mouse Model of Duchenne Muscular Dystrophy 2015 ·Scientific Reports ·Corinne Betts,Amer F. Saleh,Carolyn A. Carr,(unknown),Kim E. Wells,Suzan M. Hammond,Caroline Godfrey,Graham McClorey,(unknown),Kieran Clarke,Dominic J. Wells,Michael J. Gait,Matthew J. A. Wood	10
9	Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oligonucleotides 2015 ·Nucleic Acid Therapeutics ·Peter Järver,Eman M. Zaghloul,Andrey Arzumanov,Amer F. Saleh,Graham McClorey,Suzan M. Hammond,Mattias Hällbrink,Ülo Langel,Smith Rjh,Matthew J. A. Wood,Michael J. Gait,Samir EL Andaloussi	17
10	Transfer of genetic therapy across human populations: molecular targets for increasing patient coverage in repeat expansion diseases 2015 ·European Journal of Human Genetics ·Miguel A. Varela,Helen J Curtis,Andrew G. L. Douglas,Suzan M. Hammond,(unknown),María Jesús Sobrido,Janine Scholefield,Matthew J. A. Wood	1
11	Correlating In Vitro Splice Switching Activity With Systemic In Vivo Delivery Using Novel ZEN-modified Oligonucleotides 2014 ·Molecular Therapy — Nucleic Acids ·Suzan M. Hammond,Graham McClorey,Joel Z. Nordin,Caroline Godfrey,(unknown),Kim A. Lennox,Smith Rjh,Ashley M. Jacobi,Miguel A. Varela,(unknown),Mark A. Behlke,Matthew J. A. Wood,Samir EL Andaloussi	9
12	Use of Cell-Penetrating-Peptides in Oligonucleotide Splice Switching Therapy 2012 ·Current Gene Therapy ·(unknown),Suzan M. Hammond,Imre Mäger,Matthew J. A. Wood	18
13	Optimizing Tissue-Specific Antisense Oligonucleotide–Peptide Conjugates 2012 ·Methods in molecular biology ·Corinne Betts,Suzan M. Hammond,HaiFang Yin,Matthew J. A. Wood	5
14	Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment 2012 ·Molecular Therapy — Nucleic Acids ·Corinne Betts,Amer F. Saleh,Andrey Arzumanov,Suzan M. Hammond,Caroline Godfrey,Thibault Coursindel,Michael J. Gait,Matthew J. A. Wood	178
15	PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation 2011 ·Nucleic Acids Research ·Kariem Ezzat,Samir EL Andaloussi,Eman M. Zaghloul,Taavi Lehto,Staffan Lindberg,Pedro M. D. Moreno,Joana R. Viola,Tarek Magdy,(unknown),Peter Guterstam,Rannar Sillard,Suzan M. Hammond,Matthew J. A. Wood,Andrey Arzumanov,Michael J. Gait,Smith Rjh,Mattias Hällbrink,Ülo Langel	183
16	Pip5 Transduction Peptides Direct High Efficiency Oligonucleotide-mediated Dystrophin Exon Skipping in Heart and Phenotypic Correction in mdx Mice 2011 ·Molecular Therapy ·HaiFang Yin,Amer F. Saleh,Corinne Betts,Patrizia Camelliti,Yiqi Seow,Shirin Ashraf,Andrey Arzumanov,Suzan M. Hammond,Thomas M. Merritt,Michael J. Gait,Matthew J. A. Wood	106
17	Mouse Survival Motor Neuron Alleles That Mimic SMN2 Splicing and Are Inducible Rescue Embryonic Lethality Early in Development but Not Late 2010 ·PLoS ONE ·Suzan M. Hammond,Rocky G. Gogliotti,Vamshi K. Rao,Ariane Beauvais,Rashmi Kothary,Christine J. DiDonato	61
18	Molecular and phenotypic reassessment of an infrequently used mouse model for spinal muscular atrophy 2009 ·Biochemical and Biophysical Research Communications ·Rocky G. Gogliotti,Suzan M. Hammond,Cathleen Lutz,Christine J. DiDonato	44
19	Multiple isoforms of the KC1 cotransporter are expressed in sickle and normal erythroid cells 2005 ·Experimental Hematology ·Scott C. Crable,Suzan M. Hammond,(unknown),(unknown),Guoping Zhou,Patrick G. Gallagher,Clinton H. Joiner,Kathleen P. Anderson	34
20	Negative regulatory elements are present in the human LMO2 oncogene and may contribute to its expression in leukemia 2004 ·Leukemia Research ·Suzan M. Hammond,Scott C. Crable,Kathleen P. Anderson	32

About Suzan M. Hammond

Suzan M. Hammond is a scholar working on Genetics, Molecular Biology and Hematology, having authored 32 papers that have together received 1.4k indexed citations. Recurring topics across this work include Neurogenetic and Muscular Disorders Research (14 papers), Muscle Physiology and Disorders (12 papers) and RNA Interference and Gene Delivery (12 papers). The work is most often cited by research in Genetics (385 citations), Molecular Biology (1.2k citations) and Genetics (207 citations). Suzan M. Hammond has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Matthew J. A. Wood, Michael J. Gait, Corinne Betts, Andrey Arzumanov, Amer F. Saleh, Caroline Godfrey, Thibault Coursindel, Graham McClorey, Rocky G. Gogliotti and Christine J. DiDonato. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact